IVD Quality Control Market Projected to Grow 5.3% CAGR to $2.2B by 2031
Market research forecasts the in-vitro diagnostics quality control market will expand from $1.7B (2026) to $2.2B (2031) at 5.3% CAGR, driven by laboratory automation adoption.
How Oyticker scores a story: impact and confidence describe the information, not a probability that a price moves.
What happened
Wissen Research published a market projection showing IVD quality control market growth from USD 1.7 billion in 2026 to USD 2.2 billion by 2031, with a compound annual growth rate of 5.3%. The report attributes growth to increasing adoption of automated QC workflows in laboratory settings.
Why it matters
Automation in diagnostic labs typically reduces manual error, improves throughput, and increases demand for standardized QC solutions. This signals sustained capital investment in lab infrastructure and consumables, benefiting equipment and reagent suppliers in the diagnostics value chain.
Market transmission
First-order: increased QC equipment and software adoption by clinical and reference laboratories. Second-order: higher consumables volumes (controls, calibrators), improved lab efficiency reducing per-test costs, and potential margin expansion for automation vendors if pricing power persists.
What to watch
Actual capital equipment orders and reagent volume growth from major diagnostic lab operators; competitive pricing pressure as automation commoditizes; regulatory changes affecting QC standards; validation of the 5.3% CAGR assumption against actual market data.
Source:PR Newswire
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.